Literature DB >> 12580812

The upper and lower airway responses to nasal challenge with house-dust mite Blomia tropicalis.

D Y Wang1, D Y T Goh, A K L Ho, F T Chew, K H Yeoh, B W Lee.   

Abstract

BACKGROUND: The house dust mite Blomia tropicalis (B. tropicalis) was found to be the most prevalent domestic mite in Singapore. However, its pathogenicity in allergic airway diseases remains to be investigated.
METHODS: Twenty adults with persistent allergic rhinitis (PAR) were studied. Five had a history of asthma, and all were asymptomatic except one who was under treatment with low-dose inhaled corticosteroid. Nasal challenge was carried out by nasal spray with phosphate-buffered saline (PBS) and with increasing concentrations of crude B. tropicalis extracts (0.6, 6.0 and 60 micro g/ml) at 15 min intervals. Subjective symptom scores and absolute number of sneezes were recorded together with objective measurements of spirometry (forced expiratory volume in 1 s, FEV1) and acoustic rhinomanometry (volume of the nasal cavity). These were performed at baseline, 5 min after each incremental challenge, and 30 min, 1 h, 3 h, 5 h and 7 h after the last challenge. Meanwhile, concentrations of mediators in nasal secretions (tryptase, leukotriene C4 (LTC4) and eosinophil cationic protein (ECP)) were measured in nasal aspirate samples at similar time intervals. An identical (control) challenge procedure with PBS alone was repeated in seven patients after a washout period of at least 2 weeks.
RESULTS: Significant increases in the subjective and objective nasal symptoms, together with a significant increase of tryptase and LTC4 concentrations in nasal secretion, were found 5 min after each challenge with B. tropicalis, but not with PBS. There was no definitive pattern of the late-phase nasal response in either subjective symptoms or objective measurements. Three patients (3/5) with a history of asthma showed a fall in FEV1 readings (33%, 22% and 11% from baseline, respectively) at 7 h post challenge with concomitant mild wheezing in the night.
CONCLUSIONS: Our study demonstrates direct evidence of allergic nasal response to B. tropicalis in sensitized adults. It shows that nasal provocation may also provoke concomitant asthmatic symptoms during the late-phase reaction, especially in people with a history of asthma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12580812     DOI: 10.1034/j.1398-9995.2003.23746.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  7 in total

Review 1.  Mite immunotherapy.

Authors:  Enrique Fernández-Caldas; Victor Iraola; Manuel Boquete; Antonio Nieto; Miguel Casanovas
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

2.  Effects of leukotriene D4 nasal challenge on bronchial responsiveness and inflammation in asthmatic patients with allergic rhinitis.

Authors:  Zheng Zhu; Yanqing Xie; Weijie Guan; Yi Gao; Rongquan Huang; Shu Xia; Wenhua Jian; Zhiyu Liang; Jinping Zheng
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

3.  FeNO for detecting lower airway involvement in patients with allergic rhinitis.

Authors:  Zheng Zhu; Yanqing Xie; Weijie Guan; Yi Gao; Shu Xia; Nanshan Zhong; Jinping Zheng
Journal:  Exp Ther Med       Date:  2016-08-23       Impact factor: 2.447

Review 4.  Mite allergens.

Authors:  Enrique Fernández-Caldas; Víctor Iraola Calvo
Journal:  Curr Allergy Asthma Rep       Date:  2005-09       Impact factor: 4.806

5.  Evaluation of the applicability of the Immuno-solid-phase allergen chip (ISAC) assay in atopic patients in Singapore.

Authors:  Amelia Santosa; Anand Kumar Andiappan; Olaf Rotzschke; Hung Chew Wong; Amanda Chang; Mei Bigliardi-Qi; De-Yun Wang; Paul Lorenz Bigliardi
Journal:  Clin Transl Allergy       Date:  2015-02-27       Impact factor: 5.871

6.  Conjunctival Provocation Test With Blomia tropicalis.

Authors:  Elizabeth Maria Mercer Mourao; Nelson Augusto Rosario
Journal:  Front Allergy       Date:  2021-05-07

7.  Risk factors of allergic rhinitis: genetic or environmental?

Authors:  De-Yun Wang
Journal:  Ther Clin Risk Manag       Date:  2005-06       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.